Letaplimab represents a unique medical method for treating complement-mediated diseases. This biologic targets complement component C1q, a critical factor of the complement system, aiming to inhibit its first https://inesgvkc519666.activoblog.com/52357738/letaplimab-a-innovative-medical-strategy